July 8, 2022 Patent Open Access

Alkoclar, Erdal Can; Yesil, Metehan

Dublin Core Export

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Alkoclar, Erdal Can</dc:creator>
  <dc:creator>Yesil, Metehan</dc:creator>
  <dc:date>2022-07-08</dc:date>
  <dc:description>A bioceutical formulation consisting of RNA Polymerase inhibiting and immunomodulatory features- exhibiting Glucopyranoside Analouges for the Adjunctive Treatment of Emerging Covid-19 Subvariants.

 

Inventors: Erdal Can Alkoclar &amp; Metehan Yesil</dc:description>
  <dc:identifier>https://zenodo.org/record/24</dc:identifier>
  <dc:identifier>10.82163/sciencerepository.24</dc:identifier>
  <dc:identifier>oai:sciencerepository.dk:24</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>doi:10.82163/sciencerepository.23</dc:relation>
  <dc:relation>url:https://sciencerepository.dk/communities/science_repository_dk</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:subject>Omicron covid-19</dc:subject>
  <dc:title>An Antiviral Formulation with RNA Dependent RNA Polymerase &amp; DNA Gyrase Suppressive Properties for the Treatment of Emerging Covid-19 Subvariants</dc:title>
  <dc:type>info:eu-repo/semantics/patent</dc:type>
  <dc:type>publication-patent</dc:type>
</oai_dc:dc>